
In an extraordinary IDIBAPS Seminar, organized by coordinators of the Translational Medicine Master at UB, Dr. Carlos Fernández-Hernando spoke on June 5th about “microRNAs in vascular diseases and metabolic disease“. He is Professor at the Department of Medicine (Division of Cardiology) and Cell Biology of the Langone Medical Center, University of New York. His work focuses on determining the role of microRNAs in the metabolism of cholesterol and other related cardiovascular diseases. The event was presented by Dr. Manuel Morales, a member of the IDIBAPS Team Physiopathology and treatment of ascites and altered renal function in liver cirrhosis.

Time magazine was the first publication to announce its decision to include the malaria vaccine in its New Year list of medical breakthroughs. A few days later, the prestigious scientific journal 












